[Difference in treatment for metastatic bone tumors due to differences in opinion among departments--the role of medical teams for metastatic bone tumors].

Abstract

Few experts can deal appropriately with metastatic bone tumors in the present situation. We developed a questionnaire about zoledronic acid for doctors with several specialties, and analyzed the differences in treatment strategy among various doctors retrospectively. Breast surgeons, have used zoledronic acid appropriately based on accurate knowledge, but it has been used inappropriately by doctors of other specialties due to lack of knowledge. Development of new treatment for metastatic bone tumors is awaited, but there is a possibility of inappropriate use as with zoledronic acid because of lack of knowledge and experience. So a medical team is necessary to provide the most recent knowledge of metastatic bone tumor and to enlighten other doctors.

• Authors: Daisuke Kikuchi, Toshiro Iizuka, Naohisa Yahagi, Hirotaka Maruno, Atushi Okazaki, Yusuke Takeda, Seizou Yamamoto, Hidetaka Kawabata, Masahiro Hayashi, Kazuma Kishi
• Journal: Gan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 37 Issue 3 Pg. 473-7 (Mar 2010) ISSN: 0385-0684 [Print] Japan
• PMID: 20332686 (Publication Type: Journal Article)

Chemical References

• Diphosphonates
• Imidazoles
• Zoledronic Acid

Topics

• Bone Neoplasms (drug therapy, secondary)
• Diphosphonates (therapeutic use)
• Female
• Health Knowledge, Attitudes, Practice
• Hospital Departments
• Humans
• Imidazoles (therapeutic use)
• Japan
• Male
• Middle Aged
• Patient Care Team
• Surveys and Questionnaires
• Zoledronic Acid